{"id":5916,"date":"2025-08-28T04:57:25","date_gmt":"2025-08-28T04:57:25","guid":{"rendered":"https:\/\/packardpharmachem.com\/?page_id=5916"},"modified":"2025-09-15T05:02:13","modified_gmt":"2025-09-15T05:02:13","slug":"api-intermediates","status":"publish","type":"page","link":"https:\/\/packardpharmachem.com\/index.php\/api-intermediates\/","title":{"rendered":"API & Intermediates"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t
\n

API & Intermediates<\/h1><\/div>\n <\/section>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t

<\/span>Home<\/a><\/span><\/div>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t
\n

API & Intermediates<\/h2>
<\/div><\/div>\n <\/section>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

At Packard Pharmachem<\/strong>, we take pride in delivering Active Pharmaceutical Ingredients (APIs) and Intermediates<\/strong> that form the backbone of global healthcare solutions. Our APIs are developed with the highest standards of quality, safety, and efficacy, ensuring consistency in every batch.<\/p>

We work with a wide portfolio of APIs across multiple therapeutic areas, including cardiovascular, anti-infectives, central nervous system (CNS), gastrointestinal, pain management, nutraceuticals, and more<\/strong>. Each product is carefully researched, manufactured, and tested to comply with international regulations such as USFDA, EMA, WHO, and GMP<\/strong> guidelines.<\/p>

Our intermediates are designed to support efficient production processes, offering reliability and scalability for pharmaceutical manufacturers worldwide. With state-of-the-art facilities, robust R&D capabilities, and a strong commitment to innovation, we enable our partners to accelerate drug development and ensure timely market availability.<\/p>

By choosing us as your trusted source of APIs and Intermediates<\/strong>, you gain a partner dedicated to advancing healthcare through uncompromised quality, regulatory excellence, and sustainable practices.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t
\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
SR. No.<\/th>Type<\/th>Therapeutic Category<\/th>API Name<\/th>API Status \/ Certification<\/th>CAS Number<\/th>\n<\/tr>\n<\/thead>\n
1<\/td>API<\/td>Anthelmintic<\/td>Piperazine Phosphate<\/td>CP\/BP\/USP<\/td><\/td>\n<\/tr>\n
2<\/td>API<\/td>Anticancer series and intermediates<\/td>Oxaliplatin<\/td>CEP\/NMPA-A\/PMDA<\/td>61825-94-3<\/td>\n<\/tr>\n
3<\/td>API<\/td>Anticancer series and intermediates<\/td>Carboplatin<\/td>NMPA-A<\/td>41575-94-4<\/td>\n<\/tr>\n
4<\/td>API<\/td>Anticancer series and intermediates<\/td>Cisplatin<\/td>NMPA-I<\/td>15683-27-1<\/td>\n<\/tr>\n
5<\/td>API<\/td>Anticancer series and intermediates<\/td>Nedaplatin<\/td>DMF<\/td>95734-82-0<\/td>\n<\/tr>\n
6<\/td>API<\/td>Anticancer series and intermediates<\/td>Palbociclib<\/td>NMPA-I\/PMDA-under review<\/td>571190-30-2<\/td>\n<\/tr>\n
7<\/td>API<\/td>Anticancer series and intermediates<\/td>Ribociclib<\/td>DMF<\/td>1374589-75-4\/1211441-98-3<\/td>\n<\/tr>\n
8<\/td>API<\/td>Anticancer series and intermediates<\/td>Abemaciclib<\/td><\/td>1231929-97-7<\/td>\n<\/tr>\n
9<\/td>API<\/td>Anticancer series and intermediates<\/td>Lapatinib<\/td>DMF<\/td>388082-78-8\/88002-77-7\/231277-92-2<\/td>\n<\/tr>\n
10<\/td>API<\/td>Anticancer series and intermediates<\/td>Lenvatinib<\/td><\/td>857890-39-2\/417716-92-8<\/td>\n<\/tr>\n
11<\/td>API<\/td>Anticancer series and intermediates<\/td>Dasatinib<\/td><\/td>863127-77-9\/302962-49-8<\/td>\n<\/tr>\n
12<\/td>API<\/td>Anticancer series and intermediates<\/td>Osimertinib<\/td><\/td>1421373-66-1\/1421373-65-0<\/td>\n<\/tr>\n
13<\/td>API<\/td>Anticancer series and intermediates<\/td>Enzalutamide<\/td>NMPA-I\/PMDA-under review<\/td>915087-33-1<\/td>\n<\/tr>\n
14<\/td>API<\/td>Anticancer series and intermediates<\/td>Apalutamide<\/td><\/td>956104-40-8<\/td>\n<\/tr>\n
15<\/td>API<\/td>Anticancer series and intermediates<\/td>Olaparib<\/td><\/td>763113-22-0<\/td>\n<\/tr>\n
16<\/td>API<\/td>Anticancer series and intermediates<\/td>Niraparib<\/td><\/td>1613220-15-7\/1038915-60-4<\/td>\n<\/tr>\n
17<\/td>API<\/td>Anticancer series and intermediates<\/td>Capecitabine<\/td>CEP\/NMPA-A<\/td>154361-50-9<\/td>\n<\/tr>\n
18<\/td>API<\/td>Anticancer series and intermediates<\/td>Pemetrexed Disodium<\/td>CEP\/NMPA-A<\/td>357166-29-1\/357166-30-4<\/td>\n<\/tr>\n
19<\/td>API<\/td>Anticancer series and intermediates<\/td>Ifosfamide<\/td>DMF<\/td>3778-73-2<\/td>\n<\/tr>\n
20<\/td>API<\/td>Anticancer series and intermediates<\/td>Hydroxyurea<\/td><\/td>0127-07-01<\/td>\n<\/tr>\n
21<\/td>API<\/td>Anticancer series and intermediates<\/td>Lenalidomide<\/td><\/td>191732-72-6<\/td>\n<\/tr>\n
22<\/td>API<\/td>Anticancer series and intermediates<\/td>Bortezomib<\/td><\/td>179324-69-7<\/td>\n<\/tr>\n
23<\/td>API<\/td>Anticancer series and intermediates<\/td>Ixazomib<\/td><\/td>1072833-77-2<\/td>\n<\/tr>\n
24<\/td>API<\/td>Anticancer series and intermediates<\/td>Zoledronic Acid<\/td><\/td>165800-06-6<\/td>\n<\/tr>\n
25<\/td>API<\/td>Anticancer series and intermediates<\/td>Cyclophosphamide<\/td><\/td>6055-19-2<\/td>\n<\/tr>\n
26<\/td>API<\/td>Anticancer series and intermediates<\/td>Tegafur<\/td><\/td>17902-23-7<\/td>\n<\/tr>\n
27<\/td>API<\/td>Antifungal<\/td>Clotrimazole<\/td>CP\/BP\/USP<\/td><\/td>\n<\/tr>\n
28<\/td>API<\/td>Antifungal<\/td>Miconazole nitrate<\/td>CP\/BP\/USP<\/td><\/td>\n<\/tr>\n
29<\/td>API<\/td>Antifungal<\/td>Econazole nitrate<\/td>CP\/BP\/USP<\/td><\/td>\n<\/tr>\n
30<\/td>API<\/td>Antifungal series and Intermediates<\/td>Terbinafine Hydrochloride \/Base<\/td>NMPA-A\/CEP-under review<\/td>78628-80-5\/91161-71-6<\/td>\n<\/tr>\n
31<\/td>API<\/td>Antifungal series and Intermediates<\/td>Butenafine Hydrochloride<\/td><\/td>101827-46-7<\/td>\n<\/tr>\n
32<\/td>API<\/td>Antifungal series and Intermediates<\/td>Crisaborole<\/td>DMF<\/td>906673-24-3<\/td>\n<\/tr>\n
33<\/td>API<\/td>Antifungal series and Intermediates<\/td>Apremilast<\/td><\/td>608141-41-9<\/td>\n<\/tr>\n
34<\/td>API<\/td>Antihypertensive and lipid lowering<\/td>Ezetimibe<\/td>NMPA-A\/PMDA-under review<\/td>163222-33-1<\/td>\n<\/tr>\n
35<\/td>API<\/td>Antihypertensive and lipid lowering<\/td>Bempedoic Acid<\/td><\/td>738606-46-7<\/td>\n<\/tr>\n
36<\/td>API<\/td>Antihypertensive and lipid lowering<\/td>Mitiglinide Calcium<\/td>NMPA-A<\/td>207844-01-7<\/td>\n<\/tr>\n
37<\/td>API<\/td>Antihypertensive and lipid lowering<\/td>Empagliflozin<\/td>NMPA-I\/PMDA-under review<\/td>864070-44-0<\/td>\n<\/tr>\n
38<\/td>API<\/td>Antihypertensive and lipid lowering<\/td>Rivaroxaban<\/td>NMPA-I<\/td>366789-02-8<\/td>\n<\/tr>\n
39<\/td>API<\/td>Antihypertensive and lipid lowering<\/td>Fezolinetant<\/td><\/td>1629229-37-3<\/td>\n<\/tr>\n
40<\/td>API<\/td>Antihypertensive and lipid lowering<\/td>Cilnidipine<\/td><\/td>132203-70-4<\/td>\n<\/tr>\n
41<\/td>API<\/td>Antihypertensive and lipid lowering<\/td>Finerenone<\/td><\/td>1050477-31-0<\/td>\n<\/tr>\n
42<\/td>API<\/td>Antitubercular<\/td>Ethambutol HCl<\/td>CP\/BP\/USP<\/td><\/td>\n<\/tr>\n
43<\/td>API<\/td>Antitubercular<\/td>Isoniazid<\/td>CP\/BP\/USP<\/td><\/td>\n<\/tr>\n
44<\/td>API<\/td>Bile Therapy<\/td>Hymecromone<\/td>CP\/BP\/USP<\/td><\/td>\n<\/tr>\n
45<\/td>API<\/td>Calcium Regulator<\/td>Disodium Clodronate<\/td>CP\/BP\/USP<\/td><\/td>\n<\/tr>\n
46<\/td>API<\/td>Carbapenems<\/td>Meropenem Crude<\/td>DMF<\/td><\/td>\n<\/tr>\n
47<\/td>API<\/td>Carbapenems<\/td>Meropenem with sodium carbonate anhydrous<\/td>DMF<\/td><\/td>\n<\/tr>\n
48<\/td>API<\/td>Carbapenems<\/td>Imipenem Crude<\/td>DMF<\/td><\/td>\n<\/tr>\n
49<\/td>API<\/td>Carbapenems<\/td>Cilastatin Acid<\/td>DMF<\/td><\/td>\n<\/tr>\n
50<\/td>API<\/td>Carbapenems<\/td>Biapenem<\/td>DMF<\/td><\/td>\n<\/tr>\n
51<\/td>API<\/td>Carbapenems<\/td>Ertapenem<\/td>DMF<\/td><\/td>\n<\/tr>\n
52<\/td>API<\/td>Cephalosporins<\/td>Ceftriaxone sodium sterile<\/td>DMF<\/td><\/td>\n<\/tr>\n
53<\/td>API<\/td>Cephalosporins<\/td>Cefotaxime sodium sterile<\/td>DMF<\/td><\/td>\n<\/tr>\n
54<\/td>API<\/td>Cephalosporins<\/td>Cefoperazone sodium sterile<\/td>DMF<\/td><\/td>\n<\/tr>\n
55<\/td>API<\/td>Cephalosporins<\/td>Cefuroxime Axetil<\/td>DMF<\/td><\/td>\n<\/tr>\n
56<\/td>API<\/td>Cephalosporins<\/td>Cefuroxime sodium sterile<\/td>DMF<\/td><\/td>\n<\/tr>\n
57<\/td>API<\/td>Cephalosporins<\/td>Ceftazidime<\/td>DMF<\/td><\/td>\n<\/tr>\n
58<\/td>API<\/td>Diagnostic Agent<\/td>Fluorescein Sodium<\/td>CP\/BP\/USP<\/td><\/td>\n<\/tr>\n
59<\/td>API<\/td>Disinfectant<\/td>Methenamine<\/td>CP\/BP\/USP<\/td><\/td>\n<\/tr>\n
60<\/td>API<\/td>Disinfectant<\/td>Ethylparaben<\/td>CP<\/td><\/td>\n<\/tr>\n
61<\/td>API<\/td>Disinfectant<\/td>Chlorhexidine Acetate<\/td>CP\/BP\/USP<\/td><\/td>\n<\/tr>\n
62<\/td>API<\/td>Hormone (Estrogen)<\/td>Diethylstilbestrol<\/td>BP\/USP<\/td><\/td>\n<\/tr>\n
63<\/td>API<\/td>Hormone (Estrogen)<\/td>Hexoestrol<\/td>BPC1968<\/td><\/td>\n<\/tr>\n
64<\/td>API<\/td>NSAID<\/td>Pranoprofen<\/td>CP\/BP\/USP<\/td><\/td>\n<\/tr>\n
65<\/td>API<\/td>Other<\/td>Phenolphthalein<\/td>BP\/USP<\/td><\/td>\n<\/tr>\n
66<\/td>API<\/td>Other series and intermediates<\/td>Febuxostat<\/td>NMPA-A\/FMDA<\/td>144060-53-7<\/td>\n<\/tr>\n
67<\/td>API<\/td>Other series and intermediates<\/td>Dothurad<\/td><\/td>1285572-51-1<\/td>\n<\/tr>\n
68<\/td>API<\/td>Other series and intermediates<\/td>Racecadotril<\/td>CEP<\/td>81110-73-8<\/td>\n<\/tr>\n
69<\/td>API<\/td>Other series and intermediates<\/td>Voroprazan Fumarate<\/td>NMPA-I<\/td>1260141-27-2<\/td>\n<\/tr>\n
70<\/td>API<\/td>Other series and intermediates<\/td>Upadacitinib<\/td><\/td>2050057-66-0\/1310726-60-3<\/td>\n<\/tr>\n
71<\/td>API<\/td>Other series and intermediates<\/td>Baricitinib<\/td><\/td>1187594-09-7<\/td>\n<\/tr>\n
72<\/td>API<\/td>Other series and intermediates<\/td>Metformin Hydrochloride (DC granules)<\/td>US-FDA, KFDA, NMPA-GMP, PMDA, CEP, ANVISA<\/td>1115-70-4<\/td>\n<\/tr>\n
73<\/td>API<\/td>Other series and intermediates<\/td>Nifedipine<\/td>NMPA-GMP, CEP<\/td>21829-25-4<\/td>\n<\/tr>\n
74<\/td>API<\/td>Other series and intermediates<\/td>Felodipine<\/td>Registering...<\/td>72509-76-3<\/td>\n<\/tr>\n
75<\/td>API<\/td>Other series and intermediates<\/td>Omeprazole (7.8%\/8.5%\/12.5% pellets products)<\/td>USFDA, EU-GMP, PMDA, US-FDA, NMPA-GMP, CEP<\/td>73590-58-6<\/td>\n<\/tr>\n
76<\/td>API<\/td>Other series and intermediates<\/td>Omeprazole Magnesium<\/td>US-FDA, CEP<\/td>95382-33-5<\/td>\n<\/tr>\n
77<\/td>API<\/td>Other series and intermediates<\/td>Omeprazole Sodium<\/td>CEP<\/td>95510-70-6<\/td>\n<\/tr>\n
78<\/td>API<\/td>Other series and intermediates<\/td>Rabeprazole Sodium<\/td>NMPA-GMP, CEP<\/td>117976-90-6<\/td>\n<\/tr>\n
79<\/td>API<\/td>Other series and intermediates<\/td>Pantoprazole Sodium Sesquihydrate<\/td>US-FDA, CEP, NMPA-GMP<\/td>164579-32-2<\/td>\n<\/tr>\n
80<\/td>API<\/td>Other series and intermediates<\/td>Esomeprazole Magnesium Trihydrate\/Dihydrate (22.5% pellets product)<\/td>US-FDA, CEP, NMPA-GMP<\/td>217087-10-0 \/ 217087-09-7<\/td>\n<\/tr>\n
81<\/td>API<\/td>Other series and intermediates<\/td>Esomeprazole Sodium<\/td>CEP<\/td>161796-78-7<\/td>\n<\/tr>\n
82<\/td>API<\/td>Other series and intermediates<\/td>Clioquinol Dihydrate\/Anhydrous<\/td>EU-GMP, CEP, NMPA-GMP<\/td>6099-90-7<\/td>\n<\/tr>\n
83<\/td>API<\/td>Other series and intermediates<\/td>Trimethyl Clioquinol\/1,3,5-Trimethoxybenzene<\/td>DMF, NMPA-GMP<\/td>621-23-8<\/td>\n<\/tr>\n
84<\/td>API<\/td>Other series and intermediates<\/td>Trimethoprim<\/td>EU-GMP, US-FDA, NMPA-GMP, TGA, CEP, WHO<\/td>738-70-5<\/td>\n<\/tr>\n
85<\/td>API<\/td>Other series and intermediates<\/td>Sulfamethoxazole<\/td>US-FDA, NMPA-GMP, WHO, CEP, PMDA<\/td>723-46-6<\/td>\n<\/tr>\n
86<\/td>API<\/td>Other series and intermediates<\/td>Sulfamethoxazole Sodium<\/td>NMPA-GMP, PMDA<\/td>4563-84-2<\/td>\n<\/tr>\n
87<\/td>API<\/td>Other series and intermediates<\/td>Sulfaguanidine<\/td>GMP<\/td>57-67-0<\/td>\n<\/tr>\n
88<\/td>API<\/td>Other series and intermediates<\/td>Clozapine<\/td>US-FDA, NMPA-GMP, CEP<\/td>5786-21-0<\/td>\n<\/tr>\n
89<\/td>API<\/td>Other series and intermediates<\/td>Roxatidine Acetate Hydrochloride<\/td>NMPA-GMP<\/td>93793-83-0<\/td>\n<\/tr>\n
90<\/td>API<\/td>Other series and intermediates<\/td>LEVOFLOXACIN LACTATE<\/td>CP<\/td><\/td>\n<\/tr>\n
91<\/td>API<\/td>Other series and intermediates<\/td>LEVOFLOXACIN HCL<\/td>CP<\/td><\/td>\n<\/tr>\n
92<\/td>API<\/td>Other series and intermediates<\/td>SIMVASTATIN<\/td>CP\/USP\/IP\/EP<\/td><\/td>\n<\/tr>\n
93<\/td>API<\/td>Other series and intermediates<\/td>CIPROFLOXACIN HCL<\/td>CP\/USP\/IP\/BP<\/td><\/td>\n<\/tr>\n
94<\/td>API<\/td>Other series and intermediates<\/td>MOXIFLOXACIN<\/td>USP<\/td><\/td>\n<\/tr>\n
95<\/td>API<\/td>Other series and intermediates<\/td>MOXIFLOXACIN HCL<\/td>USP<\/td><\/td>\n<\/tr>\n
96<\/td>API<\/td>Other series and intermediates<\/td>LEVOFLOXACIN HEMHYDRATE<\/td>Enterprise Standard\/USP\/IP<\/td><\/td>\n<\/tr>\n
97<\/td>API<\/td>Other series and intermediates<\/td>OFLOXACIN<\/td>USP\/IP<\/td><\/td>\n<\/tr>\n
98<\/td>API<\/td>Other series and intermediates<\/td>NORFLOXACIN<\/td>USP\/IP<\/td><\/td>\n<\/tr>\n
99<\/td>API<\/td>Other series and intermediates<\/td>NORFLOXACIN HCL<\/td><\/td><\/td>\n<\/tr>\n
100<\/td>API<\/td>Other series and intermediates<\/td>NORFLOXACIN NICOTINATE<\/td><\/td><\/td>\n<\/tr>\n
101<\/td>API<\/td>Other series and intermediates<\/td>GATIFLOXACIN<\/td><\/td><\/td>\n<\/tr>\n
102<\/td>API<\/td>Other series and intermediates<\/td>GATIFLOXACIN HCL<\/td><\/td><\/td>\n<\/tr>\n
103<\/td>API<\/td>Other series and intermediates<\/td>GATIFLOXACIN MESYLATE<\/td><\/td><\/td>\n<\/tr>\n
104<\/td>API<\/td>Other series and intermediates<\/td>LOMEFLOXACIN<\/td><\/td><\/td>\n<\/tr>\n
105<\/td>API<\/td>Other series and intermediates<\/td>LOMEFLOXACIN HCL<\/td><\/td><\/td>\n<\/tr>\n
106<\/td>API<\/td>Other series and intermediates<\/td>SARAFLOXACIN HCL<\/td>EP\/BP<\/td><\/td>\n<\/tr>\n
107<\/td>API<\/td>Other series and intermediates<\/td>FLUMEQUINE<\/td><\/td><\/td>\n<\/tr>\n
108<\/td>API<\/td>Other series and intermediates<\/td>FLUMEQUINE SODIUM<\/td><\/td><\/td>\n<\/tr>\n
109<\/td>API<\/td>Other series and intermediates<\/td>ENROFLOXACIN HYDROCHLORIDE<\/td><\/td>67911-21-1<\/td>\n<\/tr>\n
110<\/td>API<\/td>Other series and intermediates<\/td>FLORFENICOL<\/td><\/td><\/td>\n<\/tr>\n
111<\/td>API<\/td>Other series and intermediates<\/td>MEGESTROL ACETATE<\/td>USP<\/td><\/td>\n<\/tr>\n
112<\/td>API<\/td>Other series and intermediates<\/td>MEDROXY PROGESTERONE ACETATE<\/td>USP<\/td><\/td>\n<\/tr>\n
113<\/td>API<\/td>Other series and intermediates<\/td>ABIRATERONE<\/td>Enterprise Standard<\/td><\/td>\n<\/tr>\n
114<\/td>API<\/td>Other series and intermediates<\/td>ABIRATERONE ACETATE<\/td>Enterprise Standard<\/td><\/td>\n<\/tr>\n
115<\/td>API<\/td>Other series and intermediates<\/td>FINASTERIDE<\/td>Enterprise Standard<\/td><\/td>\n<\/tr>\n
116<\/td>API<\/td>Semi-Synthetic Penicillins<\/td>Amoxicillin trihydrate powder<\/td>DMF, EU Approved, CEP<\/td><\/td>\n<\/tr>\n
117<\/td>API<\/td>Semi-Synthetic Penicillins<\/td>Amoxicillin trihydrate compacted<\/td>DMF, EU Approved, CEP<\/td><\/td>\n<\/tr>\n
118<\/td>API<\/td>Semi-Synthetic Penicillins<\/td>Amoxicillin trihydrate DC grade<\/td>DMF, EU Approved, CEP<\/td><\/td>\n<\/tr>\n
119<\/td>API<\/td>Semi-Synthetic Penicillins<\/td>Amoxicillin trihydrate Micro<\/td>DMF, EU Approved, CEP<\/td><\/td>\n<\/tr>\n
120<\/td>API<\/td>Semi-Synthetic Penicillins<\/td>Amoxicillin trihydrate sterile<\/td>DMF<\/td><\/td>\n<\/tr>\n
121<\/td>API<\/td>Semi-Synthetic Penicillins<\/td>Amoxicillin sodium sterile<\/td>DMF, EU Approved<\/td><\/td>\n<\/tr>\n
122<\/td>API<\/td>Semi-Synthetic Penicillins<\/td>Ampicillin trihydrate<\/td>DMF, EU Approved, CEP<\/td><\/td>\n<\/tr>\n
123<\/td>API<\/td>Semi-Synthetic Penicillins<\/td>Ampicillin trihydrate compacted<\/td>DMF, EU Approved, CEP<\/td><\/td>\n<\/tr>\n
124<\/td>API<\/td>Semi-Synthetic Penicillins<\/td>Ampicillin sodium sterile<\/td>DMF, EU Approved<\/td><\/td>\n<\/tr>\n
125<\/td>API<\/td>Traditional Medicine<\/td>Artificial Bezoar<\/td>CP<\/td><\/td>\n<\/tr>\n
126<\/td>API<\/td>Vitamin<\/td>Nicotinic Acid<\/td>CP\/BP\/USP<\/td><\/td>\n<\/tr>\n
127<\/td>API<\/td>\u03b2-Lactam Enzyme Inhibitor<\/td>Sulbactam sodium sterile<\/td>DMF<\/td><\/td>\n<\/tr>\n
128<\/td>API<\/td>\u03b2-Lactam Enzyme Inhibitor<\/td>Sulbactam Pivoxyl<\/td>DMF<\/td><\/td>\n<\/tr>\n
129<\/td>API\/Blend<\/td>Carbapenems<\/td>Imipenem and Cilastatin sodium with Sodium Bicarbonate<\/td>DMF<\/td><\/td>\n<\/tr>\n
130<\/td>API\/Blend<\/td>\u03b2-Lactam Enzyme Inhibitor<\/td>Clavulanate Potassium\/MCC (1:1)<\/td>DMF<\/td><\/td>\n<\/tr>\n
131<\/td>API\/Blend<\/td>\u03b2-Lactam Enzyme Inhibitor<\/td>Clavulanate Potassium\/Syloid (1:1)<\/td>DMF<\/td><\/td>\n<\/tr>\n
132<\/td>API\/Blend<\/td>\u03b2-Lactam Enzyme Inhibitor<\/td>Amoxicillin \/Clavulanate potassium (2:1,4:1,7:1)<\/td>DMF<\/td><\/td>\n<\/tr>\n
133<\/td>API\/Blend<\/td>\u03b2-Lactam Enzyme Inhibitor<\/td>Amoxicillin \/Clavulanate potassium\/MCC (4:1:1,7:1:1)<\/td>DMF<\/td><\/td>\n<\/tr>\n
134<\/td>API\/Blend<\/td>\u03b2-Lactam Enzyme Inhibitor<\/td>Amoxicillin \/Clavulanate potassium\/Syloid (4:1:1,7:1:1)<\/td>DMF<\/td><\/td>\n<\/tr>\n
135<\/td>API\/Blend<\/td>\u03b2-Lactam Enzyme Inhibitor<\/td>Amoxicillin sodium\/Clavulanate potassium (5:1) (10:1)<\/td>DMF<\/td><\/td>\n<\/tr>\n
136<\/td>API\/Blend<\/td>\u03b2-Lactam Enzyme Inhibitor<\/td>Ticarcillin sodium\/Clavulanate potassium (15:1)<\/td>DMF<\/td><\/td>\n<\/tr>\n
137<\/td>API\/Blend<\/td>\u03b2-Lactam Enzyme Inhibitor<\/td>Ampicillin sodium\/Sulbactam sodium (2:1)<\/td>DMF<\/td><\/td>\n<\/tr>\n
138<\/td>API\/Blend<\/td>\u03b2-Lactam Enzyme Inhibitor<\/td>Cefoperazone sodium\/Sulbactam sodium (1:1)<\/td>DMF, EU Approved<\/td><\/td>\n<\/tr>\n
139<\/td>API\/Blend<\/td>\u03b2-Lactam Enzyme Inhibitor<\/td>Cefoperazone sodium\/sulbactam sodium (2:1)<\/td>DMF, EU Approved<\/td><\/td>\n<\/tr>\n
140<\/td>API\/Blend<\/td>\u03b2-Lactam Enzyme Inhibitor<\/td>Amoxicillin sodium\/Sulbactam sodium (2:1)<\/td>DMF<\/td><\/td>\n<\/tr>\n
141<\/td>API\/Blend<\/td>\u03b2-Lactam Enzyme Inhibitor<\/td>Ceftriaxone sodium\/Sulbactam sodium (2:1)<\/td>DMF<\/td><\/td>\n<\/tr>\n
142<\/td>Intermediate<\/td>Antifungal series and Intermediates<\/td>Terbinafine Hydrochloride Intermediates N-methyl-1-naphthalenemethylamine<\/td><\/td>14489-75-9<\/td>\n<\/tr>\n
143<\/td>Intermediate<\/td>Antifungal series and Intermediates<\/td>3,3-Dimethyl-1-Butyne<\/td><\/td>917-92-0<\/td>\n<\/tr>\n
144<\/td>Intermediate<\/td>Antifungal series and Intermediates<\/td>1-chloro-6,6-dimethyl-2-hepten-4-yne<\/td><\/td>126764-17-8<\/td>\n<\/tr>\n
145<\/td>Intermediate<\/td>Antifungal series and Intermediates<\/td>Apremilast Intermediates 3-Aminophthalic Acid Hydrochloride<\/td><\/td>6946-22-1<\/td>\n<\/tr>\n
146<\/td>Intermediate<\/td>Antifungal series and Intermediates<\/td>3-Ethoxy-4-methoxy Benzonitrile<\/td><\/td>60758-86-3<\/td>\n<\/tr>\n
147<\/td>Intermediate<\/td>Antifungal series and Intermediates<\/td>Crisaborole Intermediate 4-(4-bromo-3-formylphenoxy)benzonitrile<\/td><\/td>906673-54-9<\/td>\n<\/tr>\n
148<\/td>Intermediate<\/td>Antihypertensive and lipid lowering<\/td>Mitiglinide Calcium Intermediates Cis-Hexahydroisoindoline Hydrochloride<\/td><\/td>161829-92-1<\/td>\n<\/tr>\n
149<\/td>Intermediate<\/td>Antihypertensive and lipid lowering<\/td>(S)-2-Benzylsuccinic Acid<\/td><\/td>3972-36-9<\/td>\n<\/tr>\n
150<\/td>Intermediate<\/td>Antihypertensive and lipid lowering<\/td>Bempedoic Acid Intermediate 2,2,14,14-tetramethyl-8-oxopentadecanedioic acid diethyl ester<\/td><\/td><\/td>\n<\/tr>\n
151<\/td>Intermediate<\/td>Other series and intermediates<\/td>Racecadotril Intermediates 2-BenzylAcrylic Acid<\/td><\/td>5669-19-2<\/td>\n<\/tr>\n
152<\/td>Intermediate<\/td>Other series and intermediates<\/td>Benzyl glycinate p-toluenesulfonate<\/td><\/td>1738-76-7<\/td>\n<\/tr>\n
153<\/td>Intermediate<\/td>Other series and intermediates<\/td>Voroprazan Fumarate Intermediates 3-pyridylsulfonyl chloride<\/td><\/td>16133-25-8<\/td>\n<\/tr>\n
154<\/td>Intermediate<\/td>Other series and intermediates<\/td>5-(2-Fluorophenyl)-1H-pyrrole-3-carboxaldehyde<\/td><\/td>861674-56-2<\/td>\n<\/tr>\n
155<\/td>Intermediate<\/td>Other series and intermediates<\/td>5-(2-Fluorophenyl)-1H-pyrrole-3-carbonitrile<\/td><\/td>1240948-77-9<\/td>\n<\/tr>\n
156<\/td>Intermediate<\/td>Other series and intermediates<\/td>Gadobutrol Intermediate 4,4-Dimethyl-3,5,6-trioxabicyclo[5.1.0]octane<\/td><\/td>57280-22-5<\/td>\n<\/tr>\n
157<\/td>Intermediate<\/td>Other series and intermediates<\/td>6-Aminopenicillanic Acid<\/td>DMF<\/td><\/td>\n<\/tr>\n
158<\/td>Intermediate<\/td>Other series and intermediates<\/td>Tert-Octylammonium Clavulanate<\/td>DMF<\/td><\/td>\n<\/tr>\n
159<\/td>Intermediate<\/td>Other series and intermediates<\/td>Penicillin G Potassium first Crystal<\/td>DMF<\/td><\/td>\n<\/tr>\n
160<\/td>Intermediate<\/td>Other series and intermediates<\/td>Tazobactam Acid<\/td>DMF<\/td><\/td>\n<\/tr>\n
161<\/td>Intermediate<\/td>Other series and intermediates<\/td>Piperacillin Acid<\/td>DMF<\/td><\/td>\n<\/tr>\n
162<\/td>Intermediate<\/td>Other series and intermediates<\/td>OFLOXACIN ETHYLESTER<\/td><\/td>107884-32-2<\/td>\n<\/tr>\n
163<\/td>Intermediate<\/td>Other series and intermediates<\/td>OFLOXACIN Q-ACID<\/td><\/td>82419-35-0<\/td>\n<\/tr>\n
164<\/td>Intermediate<\/td>Other series and intermediates<\/td>LEVOFLOXACIN ETHYLESTER<\/td><\/td>106939-34-8<\/td>\n<\/tr>\n
165<\/td>Intermediate<\/td>Other series and intermediates<\/td>LEVOFLOXACIN Q-ACID<\/td><\/td>109986-89-8<\/td>\n<\/tr>\n
166<\/td>Intermediate<\/td>Other series and intermediates<\/td>GATIFLOXACIN ETHYLESTER<\/td><\/td>112811-71-9<\/td>\n<\/tr>\n
167<\/td>Intermediate<\/td>Other series and intermediates<\/td>GATIFLOXACIN Q-ACID<\/td><\/td>112811-72-0<\/td>\n<\/tr>\n
168<\/td>Intermediate<\/td>Other series and intermediates<\/td>N-NONANE<\/td><\/td>151213-40-0<\/td>\n<\/tr>\n
169<\/td>Intermediate<\/td>Other series and intermediates<\/td>NORFLOXACIN Q-ACID<\/td><\/td>68077-26-9<\/td>\n<\/tr>\n
170<\/td>Intermediate<\/td>Other series and intermediates<\/td>CIPROFLOXACIN Q-ACID<\/td><\/td>86393-33-1<\/td>\n<\/tr>\n
171<\/td>Intermediate<\/td>Other series and intermediates<\/td>SIMVASTATIN AMMONIUM SALT<\/td><\/td>139893-43-9<\/td>\n<\/tr>\n
172<\/td>Intermediate<\/td>Other series and intermediates<\/td>2,3,4,5-TETRAFLUOROBENZOYL CHLORIDE<\/td><\/td>94695-48-4<\/td>\n<\/tr>\n
173<\/td>Intermediate<\/td>Other series and intermediates<\/td>ACETOPHENONE<\/td><\/td>98-86-2<\/td>\n<\/tr>\n
174<\/td>Intermediate<\/td>Other series and intermediates<\/td>DIBENZOYL METHANE(DBM)<\/td><\/td>120-46-7<\/td>\n<\/tr>\n
175<\/td>Intermediate<\/td>Other series and intermediates<\/td>TRIETHYL ORTHOFORMATE(TEOF)<\/td><\/td>122-51-0<\/td>\n<\/tr>\n
176<\/td>Intermediate<\/td>Other series and intermediates<\/td>EPANDROSTERONE<\/td><\/td>481-29-8<\/td>\n<\/tr>\n
177<\/td>Intermediate<\/td>Other series and intermediates<\/td>DEHYDROEPIANDROSTERONE (DHEA)<\/td><\/td>53-43-0<\/td>\n<\/tr>\n
178<\/td>Intermediate<\/td>Other series and intermediates<\/td>EPANDROSTERONE ACETATE<\/td><\/td>1239-31-2<\/td>\n<\/tr>\n
179<\/td>Intermediate<\/td>Other series and intermediates<\/td>N-T-BUTYL-4-ANDROSTEN-3-ONE-17BETA-CARBOXAMIDE<\/td><\/td>131267-80-6<\/td>\n<\/tr>\n
180<\/td>Intermediate<\/td>Other series and intermediates<\/td>DIHYDROPROSCAR<\/td><\/td>98319-24-5<\/td>\n<\/tr>\n
181<\/td>Intermediate<\/td>Other series and intermediates<\/td>PAXLOVID INTERMEDIATE<\/td><\/td>945516-54-9<\/td>\n<\/tr>\n
182<\/td>Intermediate<\/td>Other series and intermediates<\/td>PAXLOVID INTERMEDIATE<\/td><\/td>545546-57-1<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tEmail Us to Know More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

API & Intermediates Home API & Intermediates At Packard Pharmachem, we take pride in delivering Active Pharmaceutical Ingredients (APIs) and Intermediates that form the backbone of global healthcare solutions. Our APIs are developed with the highest standards of quality, safety, and efficacy, ensuring consistency in every batch. We work with a wide portfolio of APIs across multiple therapeutic areas, including cardiovascular, anti-infectives, central nervous system (CNS), gastrointestinal, pain management, nutraceuticals, and more. Each product is carefully researched, manufactured, and tested to comply with international regulations such as USFDA, EMA, WHO, and GMP guidelines. Our intermediates are designed to support efficient production processes, offering reliability and scalability for pharmaceutical manufacturers worldwide. With state-of-the-art facilities, robust R&D capabilities, and a strong commitment to innovation, we enable our partners to accelerate drug development and ensure timely market availability. By choosing us as your trusted source of APIs and Intermediates, you gain a partner dedicated to advancing healthcare through uncompromised quality, regulatory excellence, and sustainable practices. Edit SR. No. Type Therapeutic Category API Name API Status \/ Certification CAS Number 1 API Anthelmintic Piperazine Phosphate CP\/BP\/USP 2 API Anticancer series and intermediates Oxaliplatin CEP\/NMPA-A\/PMDA 61825-94-3 3 API Anticancer series and intermediates Carboplatin NMPA-A 41575-94-4 4 API Anticancer series and intermediates Cisplatin NMPA-I 15683-27-1 5 API Anticancer series and intermediates Nedaplatin DMF 95734-82-0 6 API Anticancer series and intermediates Palbociclib NMPA-I\/PMDA-under review 571190-30-2 7 API Anticancer series and intermediates Ribociclib DMF 1374589-75-4\/1211441-98-3 8 API Anticancer series and intermediates Abemaciclib 1231929-97-7 9 API Anticancer series and intermediates Lapatinib DMF 388082-78-8\/88002-77-7\/231277-92-2 10 API Anticancer series and intermediates Lenvatinib 857890-39-2\/417716-92-8 11 API Anticancer series and intermediates Dasatinib 863127-77-9\/302962-49-8 12 API Anticancer series and intermediates Osimertinib 1421373-66-1\/1421373-65-0 13 API Anticancer series and intermediates Enzalutamide NMPA-I\/PMDA-under review 915087-33-1 14 API Anticancer series and intermediates Apalutamide 956104-40-8 15 API Anticancer series and intermediates Olaparib 763113-22-0 16 API Anticancer series and intermediates Niraparib 1613220-15-7\/1038915-60-4 17 API Anticancer series and intermediates Capecitabine CEP\/NMPA-A 154361-50-9 18 API Anticancer series and intermediates Pemetrexed Disodium CEP\/NMPA-A 357166-29-1\/357166-30-4 19 API Anticancer series and intermediates Ifosfamide DMF 3778-73-2 20 API Anticancer series and intermediates Hydroxyurea 0127-07-01 21 API Anticancer series and intermediates Lenalidomide 191732-72-6 22 API Anticancer series and intermediates Bortezomib 179324-69-7 23 API Anticancer series and intermediates Ixazomib 1072833-77-2 24 API Anticancer series and intermediates Zoledronic Acid 165800-06-6 25 API Anticancer series and intermediates Cyclophosphamide 6055-19-2 26 API Anticancer series and intermediates Tegafur 17902-23-7 27 API Antifungal Clotrimazole CP\/BP\/USP 28 API Antifungal Miconazole nitrate CP\/BP\/USP 29 API Antifungal Econazole nitrate CP\/BP\/USP 30 API Antifungal series and Intermediates Terbinafine Hydrochloride \/Base NMPA-A\/CEP-under review 78628-80-5\/91161-71-6 31 API Antifungal series and Intermediates Butenafine Hydrochloride 101827-46-7 32 API Antifungal series and Intermediates Crisaborole DMF 906673-24-3 33 API Antifungal series and Intermediates Apremilast 608141-41-9 34 API Antihypertensive and lipid lowering Ezetimibe NMPA-A\/PMDA-under review 163222-33-1 35 API Antihypertensive and lipid lowering Bempedoic Acid 738606-46-7 36 API Antihypertensive and lipid lowering Mitiglinide Calcium NMPA-A 207844-01-7 37 API Antihypertensive and lipid lowering Empagliflozin NMPA-I\/PMDA-under review 864070-44-0 38 API Antihypertensive and lipid lowering Rivaroxaban NMPA-I 366789-02-8 39 API Antihypertensive and lipid lowering Fezolinetant 1629229-37-3 40 API Antihypertensive and lipid lowering Cilnidipine 132203-70-4 41 API Antihypertensive and lipid lowering Finerenone 1050477-31-0 42 API Antitubercular Ethambutol HCl CP\/BP\/USP 43 API Antitubercular Isoniazid CP\/BP\/USP 44 API Bile Therapy Hymecromone CP\/BP\/USP 45 API Calcium Regulator Disodium Clodronate CP\/BP\/USP 46 API Carbapenems Meropenem Crude DMF 47 API Carbapenems Meropenem with sodium carbonate anhydrous DMF 48 API Carbapenems Imipenem Crude DMF 49 API Carbapenems Cilastatin Acid DMF 50 API Carbapenems Biapenem DMF 51 API Carbapenems Ertapenem DMF 52 API Cephalosporins Ceftriaxone sodium sterile DMF 53 API Cephalosporins Cefotaxime sodium sterile DMF 54 API Cephalosporins Cefoperazone sodium sterile DMF 55 API Cephalosporins Cefuroxime Axetil DMF 56 API Cephalosporins Cefuroxime sodium sterile DMF 57 API Cephalosporins Ceftazidime DMF 58 API Diagnostic Agent Fluorescein Sodium CP\/BP\/USP 59 API Disinfectant Methenamine CP\/BP\/USP 60 API Disinfectant Ethylparaben CP 61 API Disinfectant Chlorhexidine Acetate CP\/BP\/USP 62 API Hormone (Estrogen) Diethylstilbestrol BP\/USP 63 API Hormone (Estrogen) Hexoestrol BPC1968 64 API NSAID Pranoprofen CP\/BP\/USP 65 API Other Phenolphthalein BP\/USP 66 API Other series and intermediates Febuxostat NMPA-A\/FMDA 144060-53-7 67 API Other series and intermediates Dothurad 1285572-51-1 68 API Other series and intermediates Racecadotril CEP 81110-73-8 69 API Other series and intermediates Voroprazan Fumarate NMPA-I 1260141-27-2 70 API Other series and intermediates Upadacitinib 2050057-66-0\/1310726-60-3 71 API Other series and intermediates Baricitinib 1187594-09-7 72 API Other series and intermediates Metformin Hydrochloride (DC granules) US-FDA, KFDA, NMPA-GMP, PMDA, CEP, ANVISA 1115-70-4 73 API Other series and intermediates Nifedipine NMPA-GMP, CEP 21829-25-4 74 API Other series and intermediates Felodipine Registering… 72509-76-3 75 API Other series and intermediates Omeprazole (7.8%\/8.5%\/12.5% pellets products) USFDA, EU-GMP, PMDA, US-FDA, NMPA-GMP, CEP 73590-58-6 76 API Other series and intermediates Omeprazole Magnesium US-FDA, CEP 95382-33-5 77 API Other series and intermediates Omeprazole Sodium CEP 95510-70-6 78 API Other series and intermediates Rabeprazole Sodium NMPA-GMP, CEP 117976-90-6 79 API Other series and intermediates Pantoprazole Sodium Sesquihydrate US-FDA, CEP, NMPA-GMP 164579-32-2 80 API Other series and intermediates Esomeprazole Magnesium Trihydrate\/Dihydrate (22.5% pellets product) US-FDA, CEP, NMPA-GMP 217087-10-0 \/ 217087-09-7 81 API Other series and intermediates Esomeprazole Sodium CEP 161796-78-7 82 API Other series and intermediates Clioquinol Dihydrate\/Anhydrous EU-GMP, CEP, NMPA-GMP 6099-90-7 83 API Other series and intermediates Trimethyl Clioquinol\/1,3,5-Trimethoxybenzene DMF, NMPA-GMP 621-23-8 84 API Other series and intermediates Trimethoprim EU-GMP, US-FDA, NMPA-GMP, TGA, CEP, WHO 738-70-5 85 API Other series and intermediates Sulfamethoxazole US-FDA, NMPA-GMP, WHO, CEP, PMDA 723-46-6 86 API Other series and intermediates Sulfamethoxazole Sodium NMPA-GMP, PMDA 4563-84-2 87 API Other series and intermediates Sulfaguanidine GMP 57-67-0 88 API Other series and intermediates Clozapine US-FDA, NMPA-GMP, CEP 5786-21-0 89 API Other series and intermediates Roxatidine Acetate Hydrochloride NMPA-GMP 93793-83-0 90 API Other series and intermediates LEVOFLOXACIN LACTATE CP 91 API Other series and intermediates LEVOFLOXACIN HCL CP 92 API Other series and intermediates SIMVASTATIN CP\/USP\/IP\/EP 93 API Other series and intermediates CIPROFLOXACIN HCL CP\/USP\/IP\/BP 94 API Other series and intermediates MOXIFLOXACIN USP 95 API Other series and intermediates MOXIFLOXACIN HCL USP 96 API Other series and intermediates LEVOFLOXACIN HEMHYDRATE<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_joinchat":[],"footnotes":""},"class_list":["post-5916","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/packardpharmachem.com\/index.php\/wp-json\/wp\/v2\/pages\/5916"}],"collection":[{"href":"https:\/\/packardpharmachem.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/packardpharmachem.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/packardpharmachem.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/packardpharmachem.com\/index.php\/wp-json\/wp\/v2\/comments?post=5916"}],"version-history":[{"count":34,"href":"https:\/\/packardpharmachem.com\/index.php\/wp-json\/wp\/v2\/pages\/5916\/revisions"}],"predecessor-version":[{"id":6593,"href":"https:\/\/packardpharmachem.com\/index.php\/wp-json\/wp\/v2\/pages\/5916\/revisions\/6593"}],"wp:attachment":[{"href":"https:\/\/packardpharmachem.com\/index.php\/wp-json\/wp\/v2\/media?parent=5916"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}